Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

Purpose

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.

Conditions

  • Obesity and Obesity-related Medical Conditions
  • Weight Loss

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject is ≥ 18 years of age at the time of the ESG procedure - Subject with a BMI between 30 kg/m2 and 50 kg/m2, inclusive, at the time of the primary ESG procedure using Overstitch Endoscopic Suturing System - Subject completed follow-up 1-year from the ESG procedure for weight loss management - Subject completed or is eligible for follow-up 5-years from the ESG procedure for weight loss management (visit can be collected either retrospectively or prospectively) - Subject has returned for a minimum of one annual follow-up at the treating site for weight loss management annually between two and four years from the procedure. - Subject is willing to complete one prospective visit (5 year or 5+ year, as appropriate) - Subject is able to read, understand, and sign a written Informed Consent Form to participate in the study

Exclusion Criteria

  • None

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Recruiting Locations

The University of Texas Health Science Center at Houston
Bellaire, Texas 77401
Contact:
Clinical Research Manager
713-486-1350
MIStreseach@uth.tmc.edu

More Details

Status
Recruiting
Sponsor
Boston Scientific Corporation

Study Contact

Maxime Oriol
978-790-8009
maxime.oriol@bsci.com

Detailed Description

Includes retrospective data collection and one prospective visit